Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: Insights from the two-year results of the COMPARE prospective randomised controlled trial

EuroIntervention

Volumn 7, Issue 12, 2012, Pages 1376-1385

  Kedhi, Elvin ^a   Gomes, Marc ^a   Joesoef, Kaiyum Sheik ^a   Wassing, Jochem ^a   Goedhart, Dick ^a   McFadden, Eugene ^a   Smits, Pieter C ^a  

^a Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

Everolimus eluting stent; Myocardial infarction; Paclitaxel eluting stents; Reinfarction; Stent thrombosis; Target vessel revascularisation

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

AGED; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 84860755900     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I12A217     Document Type: Article

References (23)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780. (Pubitemid 34586912)
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231. (Pubitemid 38067635)
3. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Ochala A, Kellock A, Parise H, Mehran R. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946-1959.
4. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
5. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel- eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 2007;369:667-678. (Pubitemid 46281313)
6. Raber L, Wohlwend L, Wigger M, Togni M, Wandel S, Wenaweser P, Cook S, Moschovitis A, Vogel R, Kalesan B, Seiler C, Eberli F, Luscher TF, Meier B, Juni P, Windecker S. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: Results of the sirolimus- eluting versus paclitaxel-eluting stents for coronary revascularization late trial. Circulation. 2011;123:2819-2828.
7. Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute st-segment elevation myocardial infarction: A follow-up study of the PASSION (paclitaxel-eluting versus conventional stent in myocardial infarction with st-segment elevation) trial. JACC Cardiovasc Interv. 2011;4:24-29.
8. Pfisterer ME. Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: A new red flag is raised. Circulation. 2008;118:1117-1119.
9. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrie D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:The SPIRIT II trial. EuroIntervention. 2006;2:286-294.
10. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA. 2008;299:1903-1913. (Pubitemid 351574920)
11. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;362: 1663-1674.
12. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial. Lancet. 2010;375:201-209.
13. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ. Randomized comparison of everolimus- and paclitaxel- eluting stents. 2-year follow-up from the SPIRIT (clinical evaluation of the xience v everolimus eluting coronary stent system) iv trial. J Am Coll Cardiol. 2011;58:19-25.
14. Smits PC, Kedhi E, Royaards KJ, Joesoef KS, Wassing J, Rademaker-Havinga TA, McFadden E. 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (comparison of the everolimus eluting xience-v stent with the paclitaxel eluting taxus liberte stent in all-comers: A randomized open label trial). J Am Coll Cardiol. 2011;58:11-18.
15. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-1513.
16. Kiaei D, Hoffman AS, Horbett TA. Tight binding of albumin to glow discharge treated polymers. J Biomater Sci Polym Ed. 1992;4:35-44.
17. Petersen RJ, Rozelle LT. Ethylcellulose perfluorobutyrate: A highly non-thrombogenic fluoropolymer for gas exchange membranes. Trans Am Soc Artif Intern Organs. 1975;21:242-248.
18. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333-342. (Pubitemid 352001347)
19. Windecker S, Serruys PW, on behalve of the RESOLUTE All Comers Investigators. Clinical and angiographic outcomes in patients with acute myocardial infarction from the resolute all comers open label randomized trial - RESOLUTE - AMI. JACC Cardiovasc Interv. 2010;56:B99.
20. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary pci in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230. (Pubitemid 351724451)
21. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093-1104. (Pubitemid 44394916)
22. De Luca G, Valgimigli M, Spaulding C, Menichelli M, Brunner-La Rocca HP, van der Hoeven BL, Di Lorenzo E, Diaz de la Llera LS, Pasceri V, Pittl U, Percoco G, Violini R, Stone GW. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. J Thromb Thrombolysis. 2009;28:200-210.
23. Manel Sabate AC, Andres Iñiguez, Antonio Serra, Rosana Hernandez-Antolin, Vicente Mainar, Marco Valgimigli, Maurizio Tespili, Armando Bethencourt, Nicolas Vazquez, Peter den Heijer, Patrick Serruys. The EXAMINATION trial: A randomized comparison between everolimus-eluting stent and bare metal stent in patients with st-segment elevation myocardial infarction ESC 2011: Hot Line III - Acute coronary syndromes (708005). 2011.